Live Breaking News & Updates on Steven Rubis

Stay updated with breaking news from Steven rubis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript


Operator
Welcome to the Q1 2021 Athenex, Inc. Earnings Conference Call. My name is Richard, and I ll be your operator for today s call. [Operator Instructions]
I am now going to call over Mr. Steven Rubis, Senior Director, Investor Relations. Steven, you may begin.
Steven Rubis
Investor Relations
Good morning, and thank you for joining our conference call. Today, we will provide an update on Athenex s business as well as a review of financial results for the first quarter of 2021. The news release detailing the results crossed the wire earlier this morning and is available on the company s website. A replay of this call will also be archived on the company website. During the conference call, the company will make projections or forward-looking statements regarding future events, including statements about financial, business and clinical milestones anticipated in fiscal year 2021 and beyond. We encourage you to review the company s past and future filings w ....

New York , United States , Gsks Dostarlimab , Robyn Karnauskas , Matt Kaplan , Johnson Lau , Rudolf Kwan , Steven Rubis , Jeff Yordon , Jeffrey Yordon , Randoll Sze , Kennen Mackay , Dan Lang , Matt Kaplan Ladenburg Thalmann , Kevin Degeeter Oppenheimer , Rudolf Kennen , Kevin Degeeter , Robyn Karnauskas Truist , Jonathan Chang , Johnson Yn Lau , Ladenburg Thalmann , Axis Therapeutics , Athenex Specialty Pharmaceuticals , Athenex Inc , Corporate Development , American Society Of Gene ,